Cong Rong, Ma Xiao-Hong, Wang Shuang, Feng Bing, Cai Wei, Chen Zhao-Wei, Zhao Xin-Ming
Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
World J Gastrointest Surg. 2023 Jan 27;15(1):9-18. doi: 10.4240/wjgs.v15.i1.9.
The post-hepatectomy recurrence rate of hepatocellular carcinoma (HCC) is persistently high, affecting the prognosis of patients. An effective therapeutic option is crucial for achieving long-term survival in patients with postoperative recurrences. Local ablative therapy has been established as a treatment option for resectable and unresectable HCCs, and it is also a feasible approach for recurrent HCC (RHCC) due to less trauma, shorter operation times, fewer complications, and faster recovery. This review focused on ablation techniques, description of potential candidates, and therapeutic and prognostic implications of ablation for guiding its application in treating intrahepatic RHCC.
肝细胞癌（HCC）肝切除术后的复发率一直居高不下，影响患者的预后。有效的治疗选择对于实现术后复发患者的长期生存至关重要。局部消融治疗已被确立为可切除和不可切除HCC的一种治疗选择，由于其创伤小、手术时间短、并发症少且恢复快，它也是复发性HCC（RHCC）的一种可行方法。本综述重点关注消融技术、潜在候选者的描述以及消融对指导其在治疗肝内RHCC中的应用的治疗和预后意义。
